Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

By PR Newswire11 days ago

AD

MEMPHIS, Tenn., Jan. 14, 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and...

Continue read on prnewswire.com